Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
302.52
+25.52 (9.21%)
Apr 20, 2026, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $8.05 billion as of April 21, 2026. Its market cap has increased by 26.01% in one year.
Market Cap
8.05B
Enterprise Value
7.90B
1-Year Change
26.01%
Ranking
Category
Stock Price
$302.52
Market Cap Chart
Since April 21, 2021, Bio-Rad Laboratories's market cap has decreased from $18.88B to $8.05B, a decrease of -57.34%. That is a compound annual growth rate of -15.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 8.18B | 0.31% |
| Dec 31, 2025 | 8.16B | -11.13% |
| Dec 31, 2024 | 9.18B | -1.27% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 19.79% |
| Apr 21, 2021 | 18.88B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Smith & Nephew | 14.68B |
| Insulet | 14.11B |
| Penumbra | 13.06B |
| Globus Medical | 12.88B |
| Masimo | 9.31B |
| Bio-Rad Laboratories | 8.07B |
| Glaukos | 7.24B |
| Bruker | 6.20B |